MIKAMINOM ANTIFUNGAL THERAPY IN NEWBORNS AND INFANTS WITH SURGICAL PATHOLOGY

Prolonged empiric and etiotropic therapy of multidrug-resistant or pan-resistant bacterial flora in different gestation age newborns has led to the growth of resistant fungalflora in intencive care units (ICU). According to risk factors and rating scales every child of ICU undergoing the abdominal c...

Full description

Saved in:
Bibliographic Details
Published inAnesteziologiia i reanimatologiia Vol. 61; no. 1; p. 40
Main Authors Melnikova, N I, Strogonov, I A, Kartseva, E V, Haritonova, G D, Gliznutsin, O E, Gabulaev, S V, Pulikova, E M
Format Journal Article
LanguageRussian
Published Russia (Federation) 01.01.2016
Subjects
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - therapeutic use
Antifungal Agents - administration & dosage
Antifungal Agents - therapeutic use
Bacterial Infections - drug therapy
Bacterial Infections - microbiology
Candida - drug effects
Candida - isolation & purification
Candidiasis - microbiology
Candidiasis - mortality
Candidiasis - prevention & control
Congenital Abnormalities - mortality
Congenital Abnormalities - surgery
Echinocandins - administration & dosage
Echinocandins - therapeutic use
Humans
Infant
Infant, Newborn
Lipopeptides - administration & dosage
Lipopeptides - therapeutic use
Microbial Sensitivity Tests
Treatment Outcome
Online AccessGet more information

Cover

More Information
Summary:Prolonged empiric and etiotropic therapy of multidrug-resistant or pan-resistant bacterial flora in different gestation age newborns has led to the growth of resistant fungalflora in intencive care units (ICU). According to risk factors and rating scales every child of ICU undergoing the abdominal cavity surgery is threatened the development of a fungal infection and requires antifungal therapy appointment or causal prophylactic. In recent years, before the advent of medications of the group of echinocandins, therapy of invasive fungal infections has been a challenge. Currently alternative drug to diflucane in neonates and infants is micafungine (mycamine) in the dose of 2-8 mg/kg/day, depending on the signs of infestation and severity of the condition.
ISSN:0201-7563